- Home
- JYD vs ATHA Comparison
JYD vs ATHA Comparison
Compare JYD & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- ATHA
- Stock Information
- Founded
- JYD 2001
- ATHA 2011
- Country
- JYD China
- ATHA United States
- Employees
- JYD N/A
- ATHA N/A
- Industry
- JYD Oil Refining/Marketing
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- JYD Consumer Discretionary
- ATHA Health Care
- Exchange
- JYD Nasdaq
- ATHA Nasdaq
- Market Cap
- JYD 18.9M
- ATHA 16.8M
- IPO Year
- JYD 2023
- ATHA 2020
- Fundamental
- Price
- JYD $4.87
- ATHA $4.05
- Analyst Decision
- JYD
- ATHA
- Analyst Count
- JYD 0
- ATHA 0
- Target Price
- JYD N/A
- ATHA N/A
- AVG Volume (30 Days)
- JYD 77.3K
- ATHA 33.3K
- Earning Date
- JYD 12-04-2025
- ATHA 11-07-2025
- Dividend Yield
- JYD N/A
- ATHA N/A
- EPS Growth
- JYD N/A
- ATHA N/A
- EPS
- JYD N/A
- ATHA N/A
- Revenue
- JYD $80,305,742.00
- ATHA N/A
- Revenue This Year
- JYD N/A
- ATHA N/A
- Revenue Next Year
- JYD N/A
- ATHA N/A
- P/E Ratio
- JYD N/A
- ATHA N/A
- Revenue Growth
- JYD N/A
- ATHA N/A
- 52 Week Low
- JYD $4.50
- ATHA $2.20
- 52 Week High
- JYD $400.00
- ATHA $8.26
- Technical
- Relative Strength Index (RSI)
- JYD 71.70
- ATHA 64.61
- Support Level
- JYD $4.81
- ATHA $3.60
- Resistance Level
- JYD $5.63
- ATHA $4.30
- Average True Range (ATR)
- JYD 0.52
- ATHA 0.24
- MACD
- JYD 0.18
- ATHA -0.09
- Stochastic Oscillator
- JYD 72.36
- ATHA 62.11
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.